Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile—commonly known ...

Newly discovered iron storage 'ferrosomes' inside the bacterium C. diff -- the leading cause of hospital-acquired infections -- are important for infection in an animal model and could offer new ...

Researchers at Tufts University School of Medicine are studying C. diff at multiple levels, from how individual bacterial ...

NEW YORK (WABC) -- We trust hospitals to help make us well. What we don't expect is to get sick in a hospital. But every year, about 648,000 hospital patients develop infections during their stay, and ...

Clostridioides difficile/Clostridium difficile (C. diff) is a bacterial infection and is the most common cause of healthcare-associated diarrhea. C. diff has two distinct presentations, primary and ...

The risk of getting a deadly, treatment-resistant infection in a hospital or nursing home is dropping for the first time in decades, thanks to new guidelines on antibiotic use and stricter cleaning ...

Each year, about 500,000 people in the U.S. deal with gastrointestinal infections from Clostridioides difficile (C. diff), and more than 20,000 die from these infections. A new study performed in mice ...

Surprising findings from a new study suggest that the burden of C. diff infection may be less a matter of hospital transmission and more a result of characteristics associated with the patients ...

Clostridium difficile bacteria, computer illustration. C. difficile is a normal inhabitant of the human intestine, but it can become a pathogen when antibiotics disrupt the normal intestinal flora and ...

The study of Clostridium difficile infection (CDI) continues to reveal intricate details of its pathogenesis, epidemiology and potential novel therapies. Research has elucidated how the bacterium, ...

Some people will get repeat infections from Clostridium difficile (C. diff). They may develop the same symptoms they had before such as diarrhea, stomach pain, and loss of appetite. However, the only ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the Clostridium difficile infections market. The report includes a detailed analysis of the pipeline molecules ...